CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The Primary objective of this study is to determine, using unblinded samples, if it is possible to develop an algorithm for the classification of spe...
Brentwood, Tennessee, United States and 1 other location
The purpose of this study (Part 1 and Part 2) is to evaluate the relative vaccine efficacy (rVE), safety, reactogenicity, and immunogenicity of mRNA-...
Phase 3
Nashville, Tennessee, United States and 217 other locations
This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI--...
Phase 2
Franklin, Tennessee, United States of America and 54 other locations
This study is an adaptive, randomized, double blind, platform trial evaluating promising investigational products (IP) for safety and efficacy as ear...
Phase 2
Nashville, Tennessee, United States and 5 other locations
seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...
Phase 3
Nashville, Tennessee, United States and 66 other locations
for teenagers. The booster targets a particular variant of COVID-19, Omicron XBB.1.5. The main focus is on safety: researchers want-...
Phase 3
Nashville, Tennessee, United States and 19 other locations
studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...
Phase 2, Phase 3
Nashville, Tennessee, United States and 114 other locations
This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary...
Phase 2, Phase 3
Nashville, Tennessee, United States and 94 other locations
doses of IgPro20 in participants with post SARS-CoV-2 infection 2019 postural orthostatic tachycardia syndrome (post-Coronavirus Disease 2019 \[COVID...
Phase 3
Nashville, Tennessee, United States and 27 other locations
The study is divided into 2 parts: Part 1 and Part 2. The purpose of Part 1 of this study is to generate sufficient safety, reactogenicity, and immun...
Phase 1, Phase 2
Hendersonville, Tennessee, United States and 68 other locations
Clinical trials
Research sites
Resources
Legal